Aclarion, Inc.
For the period ended Dec 31, 2025. Filed Mar 18, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 18, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ACLARION, INC. | |
| By: | /s/ Brent Ness |
| Brent Ness Chief Executive Officer | |
| By: | /s/ Gregory A. Gould |
| Gregory A. Gould Chief Financial Officer |
Date: March 18, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the 18th day of March, 2026.
| /s/ Jeffrey Thramann | Executive Chairman and Director |
|---|---|
| Jeffrey Thramann, M.D. | |
| /s/ Brent Ness | President, Chief Executive Officer and Director |
| Brent Ness | (Principal Executive Officer) |
| /s/ Gregory A. Gould | Chief Financial Officer |
| Gregory A. Gould | (Principal Financial and Accounting Officer) |
| /s/ Stephen Deitsch | Director |
| Stephen Deitsch | |
| /s/ David Neal | Director |
| David Neal | |
| /s/ Amanda Williams | Director |
| Amanda Williams | |
| /s/ Scott Breidbart | Director |
| Scott Breidbart, M.D. | |
| /s/ William Wesemann | Director |
| William Wesemann | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.